Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Topical SM04755 Solution Following Topical Administration to Subjects with Mild to Moderate Plaque Psoriasis

Next Previous
Trial Profile

A Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Topical SM04755 Solution Following Topical Administration to Subjects with Mild to Moderate Plaque Psoriasis

Discontinued
Phase of Trial: Phase I

Latest Information Update: 11 Jan 2019

At a glance

  • Drugs SM 04755 (Primary)
  • Indications Plaque psoriasis
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Sponsors Samumed Pacific

    • Most Recent Events

    • 04 Sep 2018 Status changed from recruiting to discontinued.
    • 04 Sep 2018 Planned End Date changed from 30 Apr 2019 to 30 Nov 2018.
    • 16 Jul 2018 The anticipated date for the last patient enrolment is 7/3/2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top